Literature DB >> 701477

Pemphigus antibody interaction with human epidermal cells in culture.

J R Schiltz, B Michel, R Papay.   

Abstract

The mechanism of pemphigus acantholysis has been studied with an in vitro system. Freshly prepared human skin epidermal cells were incubated in F-10 medium which contained the immunoglobulin G fraction from either pemphigus serum or normal human serum. During 18-h incubation periods, the pemphigus antibody became bound to the surface of the epidermal cells, caused the destruction of 75% of the viable cells as compared to only 14% in the normal immunoglobulin G controls (trypan blue exclusion), prevented the accumulation of newly synthesized proteins by nearly 60% as determined by radioactive tracer studies, and caused a dramatic shift in distribution of the newly synthesized proteins from an insoluble cell-associated fraction to an extracellular soluble fraction. These effects on the accumulation and partitioning of newly synthesized proteins were antibody concentration-dependent. Kinetic studies showed that at a fixed pemphigus antibody concentration the inhibition of protein accumulation preceded solubilization by about 1 h, at which time rapid solubilization of up to 70% of the insoluble cellular material occurred. Several lines of evidence suggested that this phenomenon was caused by enzymatic activity. Epidermal extracts solubilized a prepared substrate of radioactivity labeled insoluble epidermal cell material. This activity was heat labile and pH dependent, with pH optima ranging from 4.5 to 6.5. Enzymes with pH optima between 6 and 6.5 were recovered in the culture medium after a 2-day incubation of pure, intact epidermis with the pemphigus antibody. We proposed the following hypothesis to account for pemphigus acantholysis. The pemphigus antibody reacts with the epidermal cell surface and produces such a severe disturbance that the integrity of the cell surface is lost. As a result of these primary perturbations, the cell is killed and during the process, responds by release or activiation of soluble hydrolytic enzymes. This autolytic process results in the characteristic acantholysis of pemphigus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 701477      PMCID: PMC371829          DOI: 10.1172/JCI109189

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

Authors:  E H BEUTNER; R E JORDON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

2.  AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS.

Authors:  E H BEUTNER; W F LEVER; E WITEBSKY; R JORDON; B CHERTOCK
Journal:  JAMA       Date:  1965-05-24       Impact factor: 56.272

3.  CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM.

Authors:  R G HAM
Journal:  Proc Natl Acad Sci U S A       Date:  1965-02       Impact factor: 11.205

4.  The nature of cantharidin acantholysis.

Authors:  R B STOUGHTON; F BAGATELL
Journal:  J Invest Dermatol       Date:  1959-11       Impact factor: 8.551

5.  A study of the action of chymotrypsin on the skin.

Authors:  A SCOTT
Journal:  J Invest Dermatol       Date:  1958-04       Impact factor: 8.551

6.  Distribution of tonofibrils and intercellular bridges by disulfide-splitting agents.

Authors:  R B STOUGHTON; N NOVAK
Journal:  J Invest Dermatol       Date:  1956-02       Impact factor: 8.551

7.  Whole mounts for the study of skin and its appendages.

Authors:  G W HAMBRICK; H BLANK
Journal:  J Invest Dermatol       Date:  1954-12       Impact factor: 8.551

8.  Enzymatic cytolysis of epithelium by filtrates of feces from patients with ulcerative colitis.

Authors:  R B STOUGHTON
Journal:  Science       Date:  1952-07-11       Impact factor: 47.728

9.  Pemphigus antibody action on skin explants: kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin explants.

Authors:  J S Deng; E H Beutner; S Shu; T P Chorzelski
Journal:  Arch Dermatol       Date:  1977-07

10.  [Studies on the effect of sera taken in normal conditions and in pemphigus on normal human skin and on skin from pemphigous patients cultured in vitro].

Authors:  A G BELLONE; V LEONE
Journal:  G Ital Dermatol       Date:  1956 Mar-Apr
View more
  19 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Characterization of keratocalmin, a calmodulin-binding protein from human epidermis.

Authors:  J A Fairley; G A Scott; K D Jensen; L A Goldsmith; L A Diaz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.

Authors:  P Xia; R E Jordon; W D Geoghegan
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.

Authors:  R W Eyre; J R Stanley
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes.

Authors:  J R Stanley; M Yaar; P Hawley-Nelson; S I Katz
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

6.  Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study.

Authors:  H Dobrev; L Popova; D Vlashev
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

7.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Experimental human cell and tissue models of pemphigus.

Authors:  Gerda van der Wier; Hendri H Pas; Marcel F Jonkman
Journal:  Dermatol Res Pract       Date:  2010-05-26

9.  Apoptotic pathways in pemphigus.

Authors:  Meryem Bektas; Puneet Jolly; David S Rubenstein
Journal:  Dermatol Res Pract       Date:  2010-06-15

10.  Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells.

Authors:  S Kawana; W D Geoghegan; R E Jordon
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.